Multiple common naevi in Israeli adolescents

Melanoma Research

Volumn 16, Issue 1, 2006, Pages 89-92

  Friedman, Tal ^a   Wohl, Yonit ^a   Levin, Avi ^a   Levi, Yehezkel ^a   Brenner, Sarah ^a,b   Bar Dayan, Yosefa ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Adolescents; Exogenous factors; Melanoma; Multiple naevi phenotype

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARMY; ARTICLE; ASIAN; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; NEGRO; PATIENT INFORMATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SEX RATIO; CAUCASIAN; COHORT ANALYSIS; GEOGRAPHY; ISRAEL; PATHOLOGY; PIGMENTED NEVUS; RETROSPECTIVE STUDY; SKIN TUMOR; SUNLIGHT;

ADOLESCENT; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GEOGRAPHY; HUMANS; ISRAEL; MALE; MELANOMA; NEVUS, PIGMENTED; PHENOTYPE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT;

EID: 33645451970     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000195703.80815.98     Document Type: Article

References (26)

1. Tucker MA, Halpern A, Holly E, Hartage P, Elder DE, Sagebiel RW, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA 1997; 277:1439-1444.
2. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17:459-468.
3. Whiteman DC, Valery P, McWhirter W, Green AC. Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer 1997; 70:26-31
4. Hoang MTR, Friedlander SF. Rare cutaneous malignancies of childhood. Curr Opin Pediatr 1999; 11:464-473.
5. Kelly JW, River JK, MacLennam R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994; 30:40-48.
6. Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JA, Clark J, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. BMJ 1986; 292:1555-1559.
7. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66:387-395.
8. Bauer J, Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 2003; 16:297-306.
9. Pavlotsky F, Azizi E, Gurvich R, Lutsky A, Barell V, Weiner M, et al. Prevalence of melanocytic nevi and freckles in young Israeli males. Am J Dermatol 1997; 146:78-86.
10. Green A, Swedlow AJ. Epidemiology of melanocytic nevi. Epidemiol Rev 1989; 41:204-221.
11. Parkin DM, Steinitz R, Khlat M, Kaldor J, Katz L, Young J, et al. Cancer in Jewish migrants to Israel. Int J Cancer 1990; 45:614-621.
12. Israel Health Office. Israel cancer registry bulletin. Jerusalem: Israel Health Office; 2003.
13. Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, et al. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 2002; 94:3192-3209.
14. Carli P, Naldi L, Lovati S, La Vecchia C. The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren. Int J Cancer 2002; 101:375-379.
15. Kraemer KH, Greene MH, Taron R, Elder DE, Clark WHJ, Guerry D. Dysplastic naevi and cutaneous melanoma risk. Lancet 1983; 2:1076-1077.
16. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995; 33:1000-1007.
17. Youl P, Aitken J, Hayward N, Hogg D, Liu L, Lassam N, et al. Melanoma in adolescents: a case-control study of risk factors in Queensland Australia. Int J Cancer 2002; 98:92-98.
18. Grabe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102:700-705.
19. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF. Meta analysis of risk factors for cutaneous melanoma: common and atypical naevi. Eur J Cancer 2005; 41:28-44.
20. Gutman M, Inbar M. Malignant melanoma in different ethnic groups in Israel. Cancer 1993; 71:46-50.
21. Halpern AC, Guerry D, Elder DE, Trock B, Synnestvedt M, Humphreys T. Natural history of dysplastic nevi. J Am Acad Dermatol 1993; 29:51-57.
22. Novakovic B, Clark WH, Fears TR, Fraser MC, Tucker MA. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol 1995; 33:631-636.
23. Naeyaert JM, Brochez L. Dysplastic nevi. N Engl J Med 2003; 349:2233-2240.
24. Brenner S, Wohl Y, Landau M. Sun education in Israel. Clin Dermatol 1998; 16:517-534.
25. Bataille V, Newton Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, et al. Risk of cutaneous melanoma in relation to the number, types and sites of nevi: a case-control study. Br J Cancer 1996; 73:1605-1611.
26. Palmer JS, Duffy DL, Box NF. Melanocortin 1 receptor polymorphism and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66:176-186.